首页> 外文期刊>BMC Pulmonary Medicine >No evidence for altered intracellular calcium-handling in airway smooth muscle cells from human subjects with asthma
【24h】

No evidence for altered intracellular calcium-handling in airway smooth muscle cells from human subjects with asthma

机译:没有证据表明患有哮喘的人类受试者的气道平滑肌细胞中的细胞内钙处理发生改变

获取原文
       

摘要

Background Asthma is characterized by airway hyper-responsiveness and variable airflow obstruction, in part as a consequence of hyper-contractile airway smooth muscle, which persists in primary cell culture. One potential mechanism for this hyper-contractility is abnormal intracellular Ca2+ handling. Methods We sought to compare intracellular Ca2+ handling in airway smooth muscle cells from subjects with asthma compared to non-asthmatic controls by measuring: i) bradykinin-stimulated changes in inositol 1,4,5-trisphosphate (IP3) accumulation and intracellular Ca2+ concentration, ii) sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) expression, iii) mechanisms of cytoplasmic Ca2+ clearance assessed following instantaneous flash photolytic release of Ca2+ into the cytoplasm. Results We found no differences in airway smooth muscle cell basal intracellular Ca2+ concentrations, bradykinin-stimulated IP3 accumulation or intracellular Ca2+ responses. Quantification of SERCA2 mRNA or protein expression levels revealed no differences in ASM cells obtained from subjects with asthma compared to non-asthmatic controls. We did not identify differences in intracellular calcium kinetics assessed by flash photolysis and calcium uncaging independent of agonist-activation with or without SERCA inhibition. However, we did observe some correlations in subjects with asthma between lung function and the different cellular measurements of intracellular Ca2+ handling, with poorer lung function related to increased rate of recovery following flash photolytic elevation of cytoplasmic Ca2+ concentration. Conclusions Taken together, the experimental results reported in this study do not demonstrate major fundamental differences in Ca2+ handling between airway smooth muscle cells from non-asthmatic and asthmatic subjects. Therefore, increased contraction of airway smooth muscle cells derived from asthmatic subjects cannot be fully explained by altered Ca2+ homeostasis.
机译:背景哮喘的特征是气道高反应性和可变气流阻塞,部分原因是过度收缩的气道平滑肌(在原代细胞培养中持续存在)。这种过度收缩的潜在机制之一是异常的细胞内Ca 2 + 处理。方法我们试图通过测量以下因素来比较哮喘患者与非哮喘对照组的气道平滑肌细胞在细胞内Ca 2 + 的处理能力:i)缓激肽刺激肌醇1,4,5-三磷酸酯的变化(IP 3 )积累和细胞内Ca 2 + 浓度,ii)肌/内质网Ca 2 + -ATPase(SERCA)表达,iii Ca 2 + 瞬时瞬间光解释放到细胞质中后评估了细胞质Ca 2 + 清除的机制。结果我们发现气道平滑肌细胞基础细胞内Ca 2 + 浓度,缓激肽刺激的IP 3 积累或细胞内Ca 2 + 反应无差异。 SERCA2 mRNA或蛋白质表达水平的定量显示,与非哮喘对照组相比,哮喘患者获得的ASM细胞没有差异。我们没有确定通过快速光解和钙解笼评估的细胞内钙动力学的差异,而独立于有或没有SERCA抑制的激动剂激活。但是,我们确实观察到哮喘患者的肺功能与细胞内Ca 2 + 处理的不同细胞测量值之间存在一定的相关性,肺功能较差与细胞质Ca瞬时光解升高后恢复率增加有关 2 + 浓度。结论综上所述,本研究报告的实验结果并未证明非哮喘和哮喘患者气道平滑肌细胞在Ca 2 + 处理方面的主要根本差异。因此,不能通过改变Ca 2 + 体内稳态来充分解释哮喘患者气道平滑肌细胞收缩的增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号